Quercetin Capsules, graded Moderate-evidence on Magellan — meta-analyses show a small (~2–3 mmHg) blood-pressure reduction, mostly in people with hypertension; lipids and glucose show no meaningful effect, and oral bioavailability is poor. The headline 'senolytic' claims come from the dasatinib+quercetin drug combination in early trials — the biggest 2024 trial was negative overall — not from quercetin capsules alone.
Source: Curr Probl Cardiol 2022, PMID 35948195 ↗ · Nutraceuticals & Cellular Energizers · How Magellan grades evidence · Study write-up · evidence confidence: high
Quercetin is a flavonol, a plant polyphenol found abundantly in onions, apples, berries, capers, and tea. As one of the most common dietary flavonoids, it has antioxidant and anti-inflammatory properties and has been investigated for cardiovascular effects, particularly on blood pressure. Proposed mechanisms for its antihypertensive action include improved endothelial nitric-oxide-dependent vasodilation, inhibition of angiotensin-converting enzyme activity, and reduced oxidative stress. Quercetin is also one of the first-identified senolytic compounds, studied experimentally with the drug dasatinib to clear senescent cells.
Meta-analyses of randomized trials indicate quercetin produces a small blood-pressure reduction—on the order of 2–3 mmHg—most apparent at doses of at least 500 mg/day and in people with hypertension rather than normal blood pressure; individual trials are mixed, and a rigorous trial of purified quercetin found no vascular-function effect. Meta-analyses found no meaningful effect on lipids, glucose, or insulin measures, and quercetin's poor, variable oral bioavailability likely explains the small effect sizes. Separately, quercetin is the 'Q' in the dasatinib-plus-quercetin senolytic drug combination: a first-in-human trial found the pair cleared senescent cells and lowered inflammatory factors, but the largest 2024 randomized trial was negative overall and an Alzheimer's trial showed only safety and feasibility. Those results belong to the drug combination in early trials, not to over-the-counter capsules. This body of evidence describes the compound quercetin and its mechanisms, not this specific commercial product.
Peer-reviewed studies on the active compound — citations link to PubMed.
“quercetin supplementation significantly decreased systolic blood pressure”
“significant reductions both in systolic BP and diastolic BP following supplementation with quercetin”
“quercetin significantly lowered both systolic BP and diastolic BP”
“In a double-blind placebo-controlled trial, the bioflavonoid quercetin was well tolerated and provided significant symptomatic improvement in most men with chronic pelvic pain syndrome.”
“These findings suggest Quercetin may serve as a safe, effective adjunct in multimodal pain management protocols for cesarean delivery.”
“A random-effects meta-analysis was performed on six studies using the Osteoarthritis Research Society International (OARSI) scoring system, revealing that quercetin significantly improved OA cartilage OARSI scores (SMD, -6.30 [95% CI, -9.59 to -3.01]; P = 0.0002; heterogeneity: I2 = 86%).”
Research describes the active mechanism and is not a claim about this specific product.
Across large randomized trials and meta-analyses, marine omega-3s reliably reduce serum…
Across meta-analyses and randomized trials, creatine monohydrate combined with…
In humans, randomized trials and meta-analyses most consistently show that astaxanthin…
Multiple meta-analyses of randomized trials indicate that oral zinc, started soon after…
Yes — its active compound is linked to 25 peer-reviewed studies, summarized and cited above.
You can buy it on Amazon via the link above; Magellan earns a small affiliate commission at no extra cost to you, which does not affect the evidence grade.
Dietary supplements and devices are generally well tolerated but are not a substitute for medical care. Talk to your physician before starting, especially if you take medication or have a health condition.